A new potential cause of secondary hypertension.
作者信息
Mijalkovic Milos, Sacic Dalila
机构信息
Polyclinic Kardio Medika, Nish, Serbia.
Clinic for Cardiology, University Clinical Center of Serbia, Belgrade, Serbia.
出版信息
Front Cardiovasc Med. 2024 Aug 29;11:1458089. doi: 10.3389/fcvm.2024.1458089. eCollection 2024.
Abstract
摘要
相似文献
1
A new potential cause of secondary hypertension.继发性高血压的一种新的潜在病因。
Front Cardiovasc Med. 2024 Aug 29;11:1458089. doi: 10.3389/fcvm.2024.1458089. eCollection 2024.
2
[Hyperinsulinism/insulin resistance: cause, effect or marker of essential arterial hypertension?].[高胰岛素血症/胰岛素抵抗：原发性动脉高血压的原因、结果还是标志物？]
G Ital Cardiol. 1995 Feb;25(2):207-16.
3
Hypertension and dyslipidemia in patients with insulinoma.
Mayo Clin Proc. 1993 Feb;68(2):141-6. doi: 10.1016/s0025-6196(12)60161-x.
4
Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance.
J Am Soc Nephrol. 1992 Oct;3(4 Suppl):S64-8. doi: 10.1681/ASN.V34s64.
5
Obesity-associated hypertension. Hyperinsulinemia and renal mechanisms.肥胖相关高血压。高胰岛素血症与肾脏机制。
Hypertension. 1992 Jan;19(1 Suppl):I45-55. doi: 10.1161/01.hyp.19.1_suppl.i45.
6
Paroxysmal Hypertension Induced by an Insulinoma.胰岛素瘤所致阵发性高血压
Intern Med. 2017;56(4):413-417. doi: 10.2169/internalmedicine.56.7758. Epub 2017 Feb 15.
7
Insulin sensitivity in the pathogenesis of hypertension and hypertensive complications.
Clin Exp Hypertens. 1996 Apr-May;18(3-4):337-46. doi: 10.3109/10641969609088967.
8
Insulin resistance, hyperinsulinemia, and obesity-associated hypertension.胰岛素抵抗、高胰岛素血症与肥胖相关高血压。
J Am Soc Nephrol. 1992 Nov;3(5):1064-77. doi: 10.1681/ASN.V351064.
9
[Hyperinsulinemia and arterial hypertension].
Lijec Vjesn. 1996 Mar;118 Suppl 1:57-61.
10
Hyperinsulinemia, insulin resistance, and hypertension.高胰岛素血症、胰岛素抵抗与高血压。
J Cardiovasc Pharmacol. 1994;24 Suppl 2:S39-49.
本文引用的文献
1
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA).2023ESH 动脉高血压管理指南 欧洲高血压学会动脉高血压管理工作组：得到国际高血压学会 (ISH) 和欧洲肾脏协会 (ERA) 的认可。
J Hypertens. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. Epub 2023 Sep 26.
2
Evaluation and Management of Secondary Hypertension.继发性高血压的评估与管理。
Med Clin North Am. 2022 Mar;106(2):269-283. doi: 10.1016/j.mcna.2021.11.004. Epub 2022 Feb 2.
3
The global epidemiology of hypertension.高血压的全球流行病学。
Nat Rev Nephrol. 2020 Apr;16(4):223-237. doi: 10.1038/s41581-019-0244-2. Epub 2020 Feb 5.
4
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
5
Paroxysmal Hypertension Induced by an Insulinoma.胰岛素瘤所致阵发性高血压
Intern Med. 2017;56(4):413-417. doi: 10.2169/internalmedicine.56.7758. Epub 2017 Feb 15.
6
An unusual cause of reversible axonal neuropathy and hypertension in a 10-year-old girl.十岁女孩因罕见病因致可逆性轴索性神经病和高血压
J Clin Neurosci. 2012 Aug;19(8):1196-7. doi: 10.1016/j.jocn.2011.10.018. Epub 2012 May 20.
7
Hypertension and dyslipidemia in patients with insulinoma.
Mayo Clin Proc. 1993 Feb;68(2):141-6. doi: 10.1016/s0025-6196(12)60161-x.
8
Lack of association between blood pressure and insulin in patients with insulinoma.
J Hypertens. 1990 May;8(5):479-82. doi: 10.1097/00004872-199005000-00014.
9
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.
Diabetologia. 1992 Jul;35(7):649-52. doi: 10.1007/BF00400257.
10
Hyperinsulinaemia and blood pressure in patients with insulinoma.胰岛素瘤患者的高胰岛素血症与血压
BMJ. 1992 May 2;304(6835):1157. doi: 10.1136/bmj.304.6835.1157.
Zotero 插件